Q32 Bio Inc. QTTB

8.77 (0.45) (4.88%) as of 25 Sep
Market cap
$282.8M
P/E
2.9×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
1.43 — 0.00 0.00 0.00 0.00 0.00 0.00 — —
P/S ratio
0.00 — 0.00 21.49 5.93 191.98 523.74 120.06 — —
P/FCF ratio
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 — —
P/Operating CF
(6.61) — (0.35) (2.53) (6.62) (44.67) (33.14) (79.09) — —
P/B ratio
0.97 — 0.00 0.39 1.19 2.65 3.38 3.25 — —
EV/Sales
(0.34) — (3.34) (23.88) 2.04 117.23 366.25 79.71 — —
EV/EBITDA
0.00 — 0.00 0.57 0.00 0.00 0.00 0.00 — —
EV/FCF
(0.08) — (1.19) 0.67 (0.62) (3.23) (5.39) (6.28) — —
Current Ratio
4.85 4.97 2.04 8.02 11.14 9.69 21.54 9.84 14.85 1.88
Net Debt/EBITDA
(2.21) 1.00 (0.39) 1.09 1.52 1.65 2.53 3.66 4.48 1.17
Debt/Equity
0.23 2.23 (0.62) 0.17 0.14 0.08 0.00 0.00 0.00 0.00
ROE
125.06% 53.86% 2,174.51% (2.88%) (52.38%) (56.63%) (45.69%) (70.84%) 121.55% 32.61%
ROA
38.70% (68.49%) (39.01%) (2.27%) (40.28%) (44.82%) (36.48%) (28.03%) (39.53%) (10.61%)
ROIC
308.43% 0.00% 0.00% (256.87%) (159.02%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
66.74% (71.48%) (327.92%) (3.14%) (54.12%) (55.02%) (35.00%) (23.67%) (23.82%) (106.37%)
Average Days of Receivables
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
Earnings Yield
69.88% — (1,419.03%) (7.49%) (46.39%) (24.78%) (11.92%) (24.44%) — —
Free Cash Flow Yield
(65.18%) — (493.22%) (166.75%) (55.68%) (18.90%) (12.97%) (10.56%) — —
Free Cash Flow per Share
(2.16) (7.27) (53.51) (36.02) (36.48) (38.42) (48.33) (42.52) 32.81 (99.09)
Book value per Share
3.42 0.61 (204.74) 55.77 55.19 76.78 110.39 123.69 713.41 70.96
Free Cash Flow
(26.54) (67.79) (18.68) (114.95) (112.15) (98.06) (113.19) (67.50) 4.52 (10.47)
EV/EBIT
0.13 — 0.00 0.57 0.00 0.00 0.00 0.00 — —
Other line items

Show all line items

Columns are period end dates